Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.
Kim HI, Kim WG, Kim M, Ko NG, Jin M, Jung HA, Sun JM, Ahn JS, Ahn MJ, Choi YL, Jeon MJ, Kim TY, Kim WB, Kim SW, Lee DH, Jang SJ, Kim SW, Chung JH, Kim TH, Lee SH.
Kim HI, et al. Among authors: kim wg.
Cancer Immunol Immunother. 2024 Oct 9;73(12):260. doi: 10.1007/s00262-024-03852-w.
Cancer Immunol Immunother. 2024.
PMID: 39382668
Free PMC article.